Literature DB >> 29800213

Trends in Prescription Medication Use Among Children and Adolescents-United States, 1999-2014.

Craig M Hales1, Brian K Kit1,2, Qiuping Gu1, Cynthia L Ogden1.   

Abstract

Importance: Access to appropriate prescription medications, use of inappropriate or ineffective treatments, and adverse drug events are public health concerns among US children and adolescents. Objective: To evaluate trends in use of prescription medications among US children and adolescents. Design, Setting, and Participants: US children and adolescents aged 0 to 19 years in the 1999-2014 National Health and Nutrition Examination Survey (NHANES)-serial cross-sectional, nationally representative surveys of the civilian noninstitutionalized population. Exposures: Sex, age, race and Hispanic origin, household income and education, insurance status, current health status. Main Outcomes and Measures: Use of any prescription medications or 2 or more prescription medications taken in the past 30 days; use of medications by therapeutic class; trends in medication use across 4-year periods from 1999-2002 to 2011-2014. Data were collected though in-home interview and direct observation of the prescription container.
Results: Data on prescription medication use were available for 38 277 children and adolescents (mean age, 10 years; 49% girls). Overall, use of any prescription medication in the past 30 days decreased from 24.6% (95% CI, 22.6% to 26.6%) in 1999-2002 to 21.9% (95% CI, 20.3% to 23.6%) in 2011-2014 (β = -0.41 percentage points every 2 years [95% CI, -0.79 to -0.03]; P = .04), but there was no linear trend in the use of 2 or more prescription medications (8.5% [95% CI, 7.6% to 9.4%] in 2011-2014). In 2011-2014, the most commonly used medication classes were asthma medications (6.1% [95% CI, 5.4% to 6.8%]), antibiotics (4.5% [95% CI, 3.7% to 5.5%]), attention-deficit/hyperactivity disorder (ADHD) medications (3.5% [95% CI, 2.9% to 4.2%]), topical agents (eg, dermatologic agents, nasal steroids) (3.5% [95% CI, 3.0% to 4.1%]), and antihistamines (2.0% [95% CI, 1.7% to 2.5%]). There were significant linear trends in 14 of 39 therapeutic classes or subclasses, or in individual medications, with 8 showing increases, including asthma and ADHD medications and contraceptives, and 6 showing decreases, including antibiotics, antihistamines, and upper respiratory combination medications. Conclusions and Relevance: In this study of US children and adolescents based on a nationally representative survey, estimates of prescription medication use showed an overall decrease in use of any medication from 1999-2014. The prevalence of asthma medication, ADHD medication, and contraceptive use increased among certain age groups, whereas use of antibiotics, antihistamines, and upper respiratory combination medications decreased.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29800213      PMCID: PMC6583241          DOI: 10.1001/jama.2018.5690

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  22 in total

1.  Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report.

Authors: 
Journal:  Pediatrics       Date:  2011-11-14       Impact factor: 7.124

2.  Trends in preventive asthma medication use among children and adolescents, 1988-2008.

Authors:  Brian K Kit; Alan E Simon; Cynthia L Ogden; Lara J Akinbami
Journal:  Pediatrics       Date:  2011-12-05       Impact factor: 7.124

3.  ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser
Journal:  Pediatrics       Date:  2011-10-16       Impact factor: 7.124

4.  Over the counter but no longer under the radar--pediatric cough and cold medications.

Authors:  Joshua M Sharfstein; Marisa North; Janet R Serwint
Journal:  N Engl J Med       Date:  2007-12-06       Impact factor: 91.245

5.  Cough and cold medication use by US children, 1999-2006: results from the slone survey.

Authors:  Louis Vernacchio; Judith P Kelly; David W Kaufman; Allen A Mitchell
Journal:  Pediatrics       Date:  2008-08       Impact factor: 7.124

6.  Medication use among children <12 years of age in the United States: results from the Slone Survey.

Authors:  Louis Vernacchio; Judith P Kelly; David W Kaufman; Allen A Mitchell
Journal:  Pediatrics       Date:  2009-07-27       Impact factor: 7.124

7.  Trends of outpatient prescription drug utilization in US children, 2002-2010.

Authors:  Grace Chai; Laura Governale; Ann W McMahon; James Phillip Trinidad; Judy Staffa; Dianne Murphy
Journal:  Pediatrics       Date:  2012-06-18       Impact factor: 7.124

8.  National trends in pediatric use of anticonvulsants.

Authors:  Allen R Tran; Julie M Zito; Daniel J Safer; Sarah D Hundley
Journal:  Psychiatr Serv       Date:  2012-11       Impact factor: 3.084

9.  National trends in the office-based treatment of children, adolescents, and adults with antipsychotics.

Authors:  Mark Olfson; Carlos Blanco; Shang-Min Liu; Shuai Wang; Christoph U Correll
Journal:  Arch Gen Psychiatry       Date:  2012-12

10.  Pediatric drug surveillance and the Food and Drug Administration's adverse event reporting system: an overview of reports, 2003-2007.

Authors:  Rosemary Johann-Liang; Jo Wyeth; Min Chen; Judith U Cope
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-01       Impact factor: 2.890

View more
  40 in total

1.  Clinical Decision Support for Recognizing and Managing Hypertensive Blood Pressure in Youth: No Significant Impact on Medical Costs.

Authors:  Steven P Dehmer; Alan R Sinaiko; Nicole K Trower; Stephen E Asche; Heidi L Ekstrom; James D Nordin; Patrick J O'Connor; Elyse O Kharbanda
Journal:  Acad Pediatr       Date:  2020-01-28       Impact factor: 3.107

2.  A Randomized Controlled Trial of Interventions for Growth Suppression in Children With Attention-Deficit/Hyperactivity Disorder Treated With Central Nervous System Stimulants.

Authors:  James G Waxmonsky; William E Pelham; Adriana Campa; Daniel A Waschbusch; Tan Li; Rebecca Marshall; Lysett Babocsai; Hugh Humphery; Elizabeth Gnagy; James Swanson; Tomasz Hanć; Negar Fallahazad; William E Pelham
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-08-29       Impact factor: 8.829

3.  Chronic Medication Use in Children Insured by Medicaid: A Multistate Retrospective Cohort Study.

Authors:  James A Feinstein; Matt Hall; James W Antoon; Joanna Thomson; Juan Carlos Flores; Denise M Goodman; Eyal Cohen; Romuladus Azuine; Rishi Agrawal; Amy J Houtrow; Danielle D DeCourcey; Dennis Z Kuo; Ryan Coller; Dipika S Gaur; Jay G Berry
Journal:  Pediatrics       Date:  2019-04       Impact factor: 7.124

4.  An investigation of predictors of attendance for fathers in behavioral parent training programs for children with ADHD.

Authors:  Andrea C Nicolia; Gregory A Fabiano; Chanelle T Gordon
Journal:  Child Youth Serv Rev       Date:  2019-12-19

Review 5.  Pharmacare in Canada: The paediatric perspective.

Authors:  Tom McLaughlin; Geert 't Jong; Andrea Gilpin; Charlotte Moore Hepburn
Journal:  Paediatr Child Health       Date:  2020-03-13       Impact factor: 2.253

6.  Prescription Benzodiazepine Use in Privately Insured U.S. Children and Adolescents.

Authors:  Greta A Bushnell; Stephen Crystal; Mark Olfson
Journal:  Am J Prev Med       Date:  2019-12       Impact factor: 5.043

7.  Trends in Off-Label Drug Use in Ambulatory Settings: 2006-2015.

Authors:  Divya Hoon; Matthew T Taylor; Pooja Kapadia; Tobias Gerhard; Brian L Strom; Daniel B Horton
Journal:  Pediatrics       Date:  2019-09-16       Impact factor: 7.124

8.  Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List.

Authors:  Rachel S Meyers; Jennifer Thackray; Kelly L Matson; Christopher McPherson; Lisa Lubsch; Robert C Hellinga; David S Hoff
Journal:  J Pediatr Pharmacol Ther       Date:  2020

9.  Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children.

Authors:  Yun-Han Wang; Viktor Wintzell; Jonas F Ludvigsson; Henrik Svanström; Björn Pasternak
Journal:  JAMA Pediatr       Date:  2020-06-01       Impact factor: 16.193

Review 10.  Impact of CNS Stimulants for Attention-Deficit/Hyperactivity Disorder on Growth: Epidemiology and Approaches to Management in Children and Adolescents.

Authors:  Raman Baweja; Daniel E Hale; James G Waxmonsky
Journal:  CNS Drugs       Date:  2021-07-23       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.